Overview
Sneha Phadke is a Hematologist Oncology specialist and an Oncologist in Iowa City, Iowa. Dr. Phadke and is rated as an Experienced provider by MediFind in the treatment of Porphyria. Her top areas of expertise are Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Phadke is currently accepting new patients.
Her clinical research consists of co-authoring 17 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Sanford Health
- Wellmark
- Medica
- Humana
Locations
200 Hawkins Dr, Iowa City, IA 52242
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
State University Of Iowa
Grerk Sutamtewagul is a Hematologist Oncology specialist and an Oncologist in Iowa City, Iowa. Dr. Sutamtewagul and is rated as a Distinguished provider by MediFind in the treatment of Porphyria. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Sutamtewagul is currently accepting new patients.
Taher Abu Hejleh is an Oncologist and a Hematologist Oncology provider in Iowa City, Iowa. Dr. Abu Hejleh has been practicing medicine for over 21 years and is rated as an Advanced provider by MediFind in the treatment of Porphyria. His top areas of expertise are Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abu Hejleh is currently accepting new patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Experienced
- Fibrosarcoma
- Hereditary Coproporphyria
- Lung Cancer
- Metastatic Brain Tumor
- Pleuropulmonary Blastoma
- Porphyria